Related Experiment Video
Updated: Apr 16, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)
Dawn Nolt1, Susan Lindemulder2, Jeffrey Meyrowitz2
1Division of Infectious Diseases, Department of Pediatrics, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon.
Insights
Preventive intravenous antibiotics at the start of neutropenia in childhood acute myeloid leukemia (AML) treatment reduced infection-related deaths. This approach is safe and feasible for pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- Children with acute myeloid leukemia (AML) face high infection risk during neutropenia.
- Prophylactic antibiotics may mitigate severe infections in pediatric AML treatment.
Purpose of the Study:
- To evaluate the impact of early intravenous (IV) antibiotic use on infection incidence and outcomes in children with AML.
Main Methods:
- Retrospective analysis of pediatric patients (0-18 years) with de novo AML.
- Patients treated on COG AAML0531 or UK MRC AML 10 regimens.
- Data collected from chart reviews for 76 chemotherapy phases in 29 patients.
Main Results:
- Preventive antibiotics were given at absolute neutrophil count <500 cells/mcl before fever.
- Seven bacteremia episodes occurred, mainly coagulase-negative staphylococci and viridans group streptococci.
- One infection-related death occurred due to complications from candidal pneumonia.
Conclusions:
- Initiating preventive antibiotics at neutropenia onset showed no bacteremia-related mortality.
- This prophylactic strategy appears feasible and safe for pediatric AML patients.
Background:
Treatment of acute myeloid leukemia (AML) comes with a significant risk of life-threatening infection during periods of prolonged severe neutropenia. We studied the impact of preventive intravenous (IV) antibiotic administration at onset of absolute neutropenia on the incidence and outcome of life-threatening infections during treatment of childhood AML.
Procedures:
This is a retrospective study on pediatric patients (aged 0-18 years) consecutively diagnosed with de novo AML and treated at a single institution from April 2005 through February 2013. Patients were treated on the Children's Oncology Group (COG) AAML0531 protocol or with a modified United Kingdom Medical Research Council (UK MRC) AML 10 regimen. Pertinent data were extracted from hard copy or electronic chart review.
Results:
A total of 76 chemotherapy phases were analyzed from 29 patients. In each phase reported, preventive antibiotics were initiated when the daily absolute neutrophil count was <500 cells/mcl, before onset of fever. Seven episodes of bacteremia were documented with predominantly coagulase-negative staphylococci and viridans group streptococci. One infection-related death occurred, attributed to progressive respiratory failure occurring months after documented candidal pneumonia.
Conclusions:
Initiation of preventive antibiotics at the onset of absolute neutropenia was associated with no mortality from bacteremia. This preventive approach appears feasible and safe.
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Tonsillitis II: Management
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: